Biocon (NSE:BIOCON) YoY EBITDA Growth : -14.34% (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Biocon YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Biocon's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -14.34%.

Biocon's EBITDA per Share for the three months ended in Mar. 2024 was ₹7.95.

Biocon YoY EBITDA Growth Historical Data

The historical data trend for Biocon's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon YoY EBITDA Growth Chart

Biocon Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

6.04

-0.33

1.36

30.34

67.24

Biocon Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															97.36	78.46	74.69	275.08	-14.34

Biocon YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Biocon's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(33.98	-	20.318)	/	\| 20.318 \|
=	67.24 %

Biocon's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(7.954	-	9.286)	/	\| 9.286 \|
=	-14.34 %

Biocon YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Biocon's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocon (NSE:BIOCON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

532523:India

Address

20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100

Website

https://www.biocon.com

Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (NSE:BIOCON) Headlines

No Headlines